Anti-Progesterone Receptor 抗体 [SP2] (ab16661)

ab16661 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab16661 は 3 報の論文で使用されています。

  • Bao L  et al. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol 178:838-52 (2011). PubMed: 21281816
  • Samalecos A & Gellersen B Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms. Endocrinology 149:5872-87 (2008). WB, ICC/IF ; Human . PubMed: 18617611
  • Cano G  et al. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol 29:207-11 (2003). PubMed: 14506673

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録